Norditropin 5 mg/10 mg/15 mg per 1.5 mL Solution for injection
PDF Leaflet Revision Date: 23 December 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Growth failure due to somatropin deficiency in children.
Dosage (summary)
0.025 - 0.035 mg/kg/day for growth hormone deficiency; 0.045 - 0.067 mg/kg/day for Turner syndrome.
Special Populations
- Children
- Patients with diabetes
Pregnancy & Breastfeeding
Contraindicated in pregnancy; breastfeeding not recommended during treatment.
Key Drug Interactions
- Glucocorticoids may inhibit growth
- Increased clearance of CYP450 metabolized drugs
Contraindications
- Hypersensitivity to somatropin
- Active tumors
- Closed epiphyses
- Acute critical illness
- Proliferative diabetic retinopathy
Common side effects
- Headache
- Rash
- Arthralgia
- Injection site pain
- Peripheral edema
Counselling Points
- Inject in the evening
- Rotate injection sites
- Monitor blood glucose regularly
- Report any severe headaches or visual changes
Serious warnings
- Monitor for glucose intolerance
- Risk of benign intracranial hypertension
- Scoliosis monitoring recommended
Important Disclaimer
The Norditropin 5 mg/10 mg/15 mg per 1.5 mL Solution for injection professional information leaflet below is the property of Novo Nordisk and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
